Wockhardt’s Zaynich anti-superbug drug gets FDA approval, stock surges 16%
Mumbai: Pharmaceutical major Wockhardt Limited has achieved a historical milestone with the US Food and Drug Administration (USFDA) approving its breakthrough novel antibiotic, Zaynich. This comes after Wockhardt became the...








